Upcoming Education Program Involving New Type 1 Research Study

You are invited to attend a presentation, "Rebalancing the Immune System in Type 1 Diabetes Without Drug Therapy: The Promise of Regulatory T Cells" on Wednesday, May 18th, 6 p.m.at the UCSF Medical Center, 513 Parnassus Ave, Room N-225, San Francisco. 

Jeffrey Bluestone, PhD, UCSF Executive Vice Chancellor and Provost, and Stephen Gitelman, MD, Director of the UCSF Pediatric Diabetes Program, will be presenting their groundbreaking research involving regulatory T cells (Tregs) -- and will discuss their launch of the first Tregs human clinical trial, open to adults ages 18 to 35 who are within two years of diagnosis.

You'll also hear other clinical trial updates on preserving beta cells, and the benefits realized by all trial participants.